Target intelligence / Profile preview

Salivary film and residual saliva

Molecular classification
Other
01

Overview

The salivary film and residual saliva represent the physiological liquid environment of the oral cavity, serving as a critical interface for oral health and function (Humphrey & Williamson, 2001). The salivary film is a thin layer, approximately 70 to 100 micrometers thick, that coats the oral mucosa and teeth, while residual saliva is the volume of fluid remaining in the mouth after swallowing, typically ranging from 0.5 to 1.0 milliliters (Dawes, 2008). This system is not a discrete molecular target like a receptor or enzyme; rather, it is a complex biological matrix composed of water, electrolytes, and proteins such as mucins and lysozyme that provide lubrication, buffering, and antimicrobial protection (Nieuw Amerongen et al., 2007). In conditions like xerostomia or Sjogren's syndrome, the reduction or alteration of this film leads to significant morbidity, including dental caries and oral infections (NIH, 2023). Drugs such as pilocarpine and cevimeline target the production of this fluid by acting as cholinergic agonists, while various saliva substitutes are designed to physically replenish the film to alleviate symptoms (StatPearls, 2023). Understanding the dynamics of the salivary film is also vital for optimizing transmucosal drug delivery, as the film's thickness and turnover rate directly influence drug dissolution and absorption (Journal of Controlled Release, 2011).

Other names
Salivary pellicleResidual salivary volumeOral fluid filmMucosal pellicleSalivary film thickness
02

Mechanism of action

Pharmacological agents interact with this system by either stimulating the autonomic nervous system to increase endogenous secretion or by providing exogenous polymers that mimic the viscoelastic and lubricating properties of the natural salivary film.

03

Biological functions

LubricationOral mucosal protectionBuffering capacityAntimicrobial defenseRemineralizationTissue hydration
04

Disease associations

XerostomiaDental cariesOral candidiasisSjogren's syndromeBurning mouth syndrome
05

Safety considerations

Systemic cholinergic side effects from secretagoguesShort duration of action for topical substitutesPotential for aspiration in patients with impaired swallow reflex
06

Interacting drugs

Pilocarpine

4 more in the full profile.

07

Biomarkers

Unstimulated salivary flow rateStimulated salivary flow rateSalivary pHMucin concentration

Beyond the preview

Go deeper on Salivary film and residual saliva.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salivary film and residual saliva.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call